Value of MELD 3.0， MELD， and MELD-Na scores in assessing the short-term prognosis of patients with acute-on-chronic liver failure： A comparative study

Beichen GUO; Yuhan LI; Rui CHEN; Lewei WANG; Ying LI; Fang LIU; Manman XU; Yu CHEN; Zhongping DUAN; Shaojie XIN; Tao HAN

doi:10.3969/j.issn.1001-5256.2023.11.018

Volume 39 Issue 11

Nov. 2023

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2023 > 39(11): 2635-2642

PDF( 824 KB)

Value of MELD 3.0， MELD， and MELD-Na scores in assessing the short-term prognosis of patients with acute-on-chronic liver failure： A comparative study

DOI: 10.3969/j.issn.1001-5256.2023.11.018

1.
Department of Gastroenterology and Hepatology，Tianjin Union Medical Center，Tianjin Medical University，Tianjin 300121，China
2.
Department of Gastroenterology and Hepatology，Tianjin Third Central Hospital，Tianjin 300170，China
3.
Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research，Beijing YouAn Hospital，Capital Medical University，Beijing 100069，China
4.
Department of Liver Diseases，The Fifth Medical Center of Chinese PLA General Hospital，Beijing 100039，China
5.
Department of Gastroenterology and Hepatology，Tianjin Union Medical Center，Nankai University，Tianjin 300121，China

Research funding:

The 13th Five-Year National Science and Technology Major Project for Infectious Diseases (2017ZX10203201007);

National Natural Science Foundation of China (82170630)

More Information

Corresponding author: HAN Tao， hantaomd@126.com （ORCID： 0000-0003-4216-6968）
Received Date: 2022-11-25
Accepted Date: 2023-05-22
Published Date: 2023-11-28

Abstract

Abstract

Objective To investigate the value of MELD 3.0， MELD， and MELD-Na scores in assessing the 90-day prognosis of patients with acute-on-chronic liver failure （ACLF） through a comparative study. Methods A retrospective analysis was performed for the clinical data of 605 patients with ACLF who were treated in Tianjin Third Central Hospital， The Fifth Medical Center of Chinese PLA General Hospital， and Beijing YouAn Hospital from November 2012 to June 2019， and according to the 90-day follow-up results after admission， they were divided into survival group with 392 patients and death group with 213 patients. The receiver operating characteristic （ROC） curve， the area under the ROC curve （AUC）， net reclassification improvement （NRI）， integrated discrimination improvement （IDI）， and decision curve analysis （DCA） curve were used to investigate the value of MELD 3.0， MELD， and MELD-Na scores at baseline， day 3， week 1， and week 2 in predicting the prognosis of the disease. Results At day 3 and week 1， MELD 3.0 score had an AUC of 0.775 and 0.808， respectively， with a better AUC than MELD score （P<0.05）. At day 3， week 1， and week 2， MELD 3.0 score showed an NRI of 0.125， 0.100， and 0.081， respectively， compared with MELD in predicting the prognosis of ACLF patients， as well as an NRI of 0.093， 0.140， and 0.204， respectively， compared with MELD-Na score in predicting prognosis. At baseline， day 3， week 1， and week 2， MELD 3.0 showed an IDI of 0.011， 0.025， 0.017， and 0.013， respectively， compared with MELD in predicting the prognosis of ACLF patients. At day 3 and week 2， MELD 3.0 showed an IDI of 0.027 and 0.038， respectively， compared with MELD-Na in predicting the prognosis of ACLF patients. All the above NRIs and IDIs were >0， indicating a positive improvement （all P<0.05）. DCA curves showed that MELD 3.0 was superior to MELD at day 3 and was significantly superior to MELD-Na at week 2. There was no significant difference in the ability of the three scores in predicting the prognosis of ACLF patients with different types， and there was also no significant difference in the ability of the three scores in predicting the prognosis of ACLF patients with the etiology of HBV infection， alcohol， or HBV infection combined with alcohol， while MELD 3.0 was superior to MELD for ACLF patients with other etiologies （P<0.05）. Conclusion MELD 3.0 score is better than MELD and MELD-Na scores in predicting the 90-day survival of patients with ACLF， but with limited superiority.
- Acute-On-Chronic Liver Failure,
- MELD-Na Score,
- MELD 3.0 Score,
- MELD Score,
- Prognosis

FullText(HTML)

References(20)

References

[1]	Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007. 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
[2]	ARROYO V, MOREAU R, JALAN R. Acute-on-chronic liver failure[J]. N Engl J Med, 2020, 382( 22): 2137- 2145. DOI: 10.1056/NEJMra1914900.
[3]	HERNAEZ R, SOLÀ E, MOREAU R, et al. Acute-on-chronic liver failure: An update[J]. Gut, 2017, 66( 3): 541- 553. DOI: 10.1136/gutjnl-2016-312670.
[4]	FAN Q, LI Z. Liver transplantation for acute-on-chronic liver failure[J]. Organ Transplant, 2022, 13( 3): 333- 337. DOI: 10.3969/j.issn.1674-7445.2022.03.008. 范祺, 李照. 慢加急性肝衰竭的肝移植治疗[J]. 器官移植, 2022, 13( 3): 333- 337. DOI: 10.3969/j.issn.1674-7445.2022.03.008.
[5]	BI ZH, WANG LX, LIAN JQ. Definition, prognostic assessment, and advances in the diagnosis and treatment of acute-on-chronic liver failure[J]. J Clin Hepatol, 2022, 38( 7): 1671- 1676. DOI: 10.3969/j.issn.1001-5256.2022.07.041. 毕占虎, 王临旭, 连建奇. 慢加急性肝衰竭的定义、预后评估及诊治进展[J]. 临床肝胆病杂志, 2022, 38( 7): 1671- 1676. DOI: 10.3969/j.issn.1001-5256.2022.07.041.
[6]	ZACCHERINI G, WEISS E, MOREAU R. Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment[J]. JHEP Rep, 2020, 3( 1): 100176. DOI: 10.1016/j.jhepr.2020.100176.
[7]	KARVELLAS CJ, FRANCOZ C, WEISS E. Liver transplantation in acute-on-chronic liver failure[J]. Transplantation, 2021, 105( 7): 1471- 1481. DOI: 10.1097/TP.0000000000003550.
[8]	KIM WR, MANNALITHARA A, HEIMBACH JK, et al. MELD 3.0: The model for end-stage liver disease updated for the modern era[J]. Gastroenterology, 2021, 161( 6): 1887- 1895. DOI: 10.1053/j.gastro.2021.08.050.
[9]	KAMATH PS, KIM WR. The model for end-stage liver disease(MELD)[J]. Hepatology, 2007, 45( 3): 797- 805. DOI: 10.1002/hep.21563.
[10]	KAMATH PS, WIESNER RH, MALINCHOC M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33( 2): 464- 470. DOI: 10.1053/jhep.2001.22172.
[11]	BIGGINS SW, KIM WR, TERRAULT NA, et al. Evidence-based incorporation of serum sodium concentration into MELD[J]. Gastroenterology, 2006, 130( 6): 1652- 1660. DOI: 10.1053/j.gastro.2006.02.010.
[12]	MALINCHOC M, KAMATH PS, GORDON FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J]. Hepatology, 2000, 31( 4): 864- 871. DOI: 10.1053/he.2000.5852.
[13]	ABDALLAH MA, KUO YF, ASRANI S, et al. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality[J]. J Hepatol, 2021, 74( 6): 1355- 1361. DOI: 10.1016/j.jhep.2020.12.003.
[14]	MEZZANO G, JUANOLA A, CARDENAS A, et al. Global burden of disease: Acute-on-chronic liver failure, a systematic review and meta-analysis[J]. Gut, 2022, 71( 1): 148- 155. DOI: 10.1136/gutjnl-2020-322161.
[15]	GOUDSMIT BFJ, BRAAT AE, TUSHUIZEN ME, et al. Development and validation of a dynamic survival prediction model for patients with acute-on-chronic liver failure[J]. JHEP Rep, 2021, 3( 6): 100369. DOI: 10.1016/j.jhepr.2021.100369.
[16]	HA JM, SOHN W, CHO JY, et al. Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure[J]. Clin Mol Hepatol, 2015, 21( 3): 232- 241. DOI: 10.3350/cmh.2015.21.3.232.
[17]	CHEN MJ, LI X, TANG SH. Progress of multidimensional evaluation of liver function in prognosis of patients with liver failure[J]. Clin J Med Offic, 2023, 51( 9): 901- 903, 907. DOI: 10.16680/j.1671-3826.2023.09.05. 陈美娟, 李雪, 汤善宏. 多维度评估肝功能在肝衰竭患者预后中研究进展[J]. 临床军医杂志, 2023, 51( 9): 901- 903, 907. DOI: 10.16680/j.1671-3826.2023.09.05.
[18]	GUSTOT T, FERNANDEZ J, GARCIA E, et al. Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis[J]. Hepatology, 2015, 62( 1): 243- 252. DOI: 10.1002/hep.27849.
[19]	YU ZJ, ZHANG Y, CAO YY, et al. A dynamic prediction model for prognosis of acute-on-chronic liver failure based on the trend of clinical indicators[J]. Sci Rep, 2021, 11( 1): 1810. DOI: 10.1038/s41598-021-81431-0.
[20]	LIU WS, SHEN LJ, TIAN H, et al. ABC prognostic classification and MELD 3.0 and COSSH-ACLF II prognostic evaluation in acute-on-chronic liver failure[J]. Chin J Hepatol, 2022, 30( 9): 976- 980. DOI: 10.3760/cma.j.cn501113-20220308-00103. 刘婉姝, 申力军, 田华, 等. 慢加急性肝衰竭ABC分型的预后及MELD 3.0和COSSH-ACLFII对预后评估[J]. 中华肝脏病杂志, 2022, 30( 9): 976- 980. DOI: 10.3760/cma.j.cn501113-20220308-00103.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(2) / Tables(5)

Get Citation

PDF

XML

Article Metrics

Article views (421) PDF downloads(46)

Value of MELD 3.0， MELD， and MELD-Na scores in assessing the short-term prognosis of patients with acute-on-chronic liver failure： A comparative study

DOI: 10.3969/j.issn.1001-5256.2023.11.018

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Value of MELD 3.0， MELD， and MELD-Na scores in assessing the short-term prognosis of patients with acute-on-chronic liver failure： A comparative study

DOI: 10.3969/j.issn.1001-5256.2023.11.018

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content